Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
SeaStar Medical Holding Corporation
AI Executive Summary
AI-powered analysis of 8-K filing content
SeaStar Medical's stockholders approved an amendment to the 2022 Omnibus Incentive Plan on June 17, 2026, increasing authorized equity award shares from 207,046 to 896,546 shares. This expansion enables the company to offer more equity incentives to attract and retain talent while supporting long-term growth objectives.
Key Takeaways
The 2022 Omnibus Incentive Plan was amended to increase authorized shares by 689,500 shares (333% increase), significantly expanding equity compensation capacity
The amendment was approved at the annual stockholder meeting, indicating shareholder support for the company's talent retention and incentive strategy
1 more takeaway
Related Filings (1)
1 more filing from SeaStar Medical Holding Corporation in the last 90 days